このページの翻訳は実験的なもので、現在開発中です。お待ちしております

RadNet 過去の業績

過去基準チェック /26

RadNetの収益は年間平均-18.8%の割合で減少していますが、 Healthcare業界の収益は年間減少しています。収益は年間0.9% 9.6%割合で増加しています。 RadNetの自己資本利益率は4.6%であり、純利益率は1.3%です。

主要情報

-12.2%

収益成長率

-16.0%

EPS成長率

Healthcare 業界の成長	15.7%
収益成長率	9.8%
株主資本利益率	3.9%
ネット・マージン	0.6%
前回の決算情報	30 Jun 2024

Recent updates

収支内訳

RadNet の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

DB:PQIA 収益、費用、利益 ( )USD Millions
日付	収益	収益	G+A経費
30 Jun 24	1,714	10	142
31 Mar 24	1,658	21	142
31 Dec 23	1,617	3	142
30 Sep 23	1,580	4	141
30 Jun 23	1,528	-13	142
31 Mar 23	1,479	-13	173
31 Dec 22	1,430	11	144
30 Sep 22	1,382	8	92
30 Jun 22	1,365	23	61
31 Mar 22	1,344	18	0
31 Dec 21	1,324	25	0
30 Sep 21	1,297	35	108
30 Jun 21	1,256	24	55
31 Mar 21	1,138	11	81
31 Dec 20	1,098	-15	0
30 Sep 20	1,090	-10	106
30 Jun 20	1,091	-13	108
31 Mar 20	1,164	2	133
31 Dec 19	1,154	15	0
30 Sep 19	1,111	33	24
30 Jun 19	1,060	35	99
31 Mar 19	1,015	36	90
31 Dec 18	975	32	0
30 Sep 18	953	-4	85
30 Jun 18	939	-6	83
31 Mar 18	925	-6	59
31 Dec 17	922	0	0
30 Sep 17	912	11	77
30 Jun 17	909	9	74
31 Mar 17	897	7	75
31 Dec 16	885	7	74
30 Sep 16	875	5	75
30 Jun 16	859	11	76
31 Mar 16	845	11	74
31 Dec 15	810	8	72
30 Sep 15	779	11	70
30 Jun 15	755	7	68
31 Mar 15	730	9	66
31 Dec 14	718	1	64
30 Sep 14	710	-2	63
30 Jun 14	701	-7	63
31 Mar 14	699	-9	64
31 Dec 13	703	2	65
30 Sep 13	684	53	65

質の高い収益: PQIAは高品質の収益を持っています。

利益率の向上: PQIA過去に利益を上げました。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: PQIAの収益は過去 5 年間で年間18.8%減少しました。

成長の加速: PQIAは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。

収益対業界: PQIA昨年収益を上げたため、昨年の収益成長をHealthcare業界 ( -2.2% ) と比較することは困難です。

株主資本利益率

高いROE: PQIAの自己資本利益率 ( 4.6% ) は低いとみなされます。

RadNet 過去の業績

過去 基準チェック /26

主要情報

最近の業績更新

Second quarter 2024 earnings released: US$0.041 loss per share (vs US$0.14 profit in 2Q 2023)

First quarter 2024 earnings released: US$0.04 loss per share (vs US$0.36 loss in 1Q 2023)

Full year 2023 earnings released: EPS: US$0.048 (vs US$0.19 in FY 2022)

Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.012 in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2022)

First quarter 2023 earnings released: US$0.36 loss per share (vs US$0.054 profit in 1Q 2022)

Recent updates

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

Insider recently sold €846k worth of stock

Second quarter 2024 earnings released: US$0.041 loss per share (vs US$0.14 profit in 2Q 2023)

New minor risk - Share price stability

Insufficient new directors

Executive VP recently sold €930k worth of stock

First quarter 2024 earnings released: US$0.04 loss per share (vs US$0.36 loss in 1Q 2023)

RadNet, Inc., Annual General Meeting, Jun 12, 2024

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Now 23% overvalued after recent price rise

Full year 2023 earnings released: EPS: US$0.048 (vs US$0.19 in FY 2022)

Insider recently sold €328k worth of stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.012 in 3Q 2022)

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2022)

Radnet, Inc. Revises Earnings Guidance for the Year 2023

RadNet, Inc. Announces Appointment of Executives

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold €1.3m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

Board Member recently sold €128k worth of stock

RadNet, Inc., Annual General Meeting, Jun 07, 2023

RadNet, Inc. Revises Earnings Guidance for the Year 2023

First quarter 2023 earnings released: US$0.36 loss per share (vs US$0.054 profit in 1Q 2022)

President & COO of Eastern Operations recently sold €217k worth of stock

Insider recently sold €418k worth of stock

Full year 2022 earnings released: EPS: US$0.19 (vs US$0.47 in FY 2021)

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold €92k worth of stock

Third quarter 2022 earnings released: EPS: US$0.012 (vs US$0.31 in 3Q 2021)

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: US$0.14 (vs US$0.055 in 2Q 2021)

RadNet, Inc. Updates Earnings Guidance for 2022

President & COO of Western Operations recently sold €193k worth of stock

RadNet, Inc. Announces That It Has Received FDA Clearances for Its DeepHeatlh Saige-DX™ Mammography and Quantib® Prostate 2.0 MRI Artificial Intelligence ("Ai") Algorithms

First quarter 2022 earnings released: EPS: US$0.054 (vs US$0.18 in 1Q 2021)

RadNet, Inc. Revises Earnings Guidance for the Fiscal Year 2022

RadNet, Inc., Annual General Meeting, Jun 08, 2022

RadNet, Inc. Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

RadNet, Inc. (NasdaqGM:RDNT) acquired Quantib B.V. for $45 million.

Third quarter 2021 earnings released: EPS US$0.31 (vs US$0.12 in 3Q 2020)

Senior VP of Human Resources & Director recently sold €86k worth of stock

Investor sentiment deteriorated over the past week

Lead Independent Director recently bought €129k worth of stock

Second quarter 2021 earnings released: EPS US$0.055 (vs US$0.21 loss in 2Q 2020)

Senior VP of Human Resources & Director recently sold €388k worth of stock

Independent Director Marvin Cadwell has left the company

VP, Medical Director & Director John Crues has left the company

Insider recently sold €404k worth of stock

Independent Director recently bought €238k worth of stock

First quarter 2021 earnings released: EPS US$0.18 (vs US$0.33 loss in 1Q 2020)

RadNet, Inc. Revises Earnings Guidance for the Year 2021

Independent Director recently sold €397k worth of stock

Full year 2020 earnings released: US$0.29 loss per share (vs US$0.30 profit in FY 2019)

Revenue beats expectations

New 90-day high: €19.90

RadNet and its Partner Dignity Health, Plaza Companies and Holualoa Companies Team Up to Redevelop Park Central

New 90-day high: €17.00

President & COO of Western Operations recently sold €236k worth of stock

Third quarter 2020 earnings released: EPS US$0.12

Revenue beats expectations

過去基準チェック /26